| Dr Mark D Matthews, DO | |
|
1011 Main St, Cassville, MO 65625-1335 | |
| (417) 846-2277 | |
| Not Available |
| Full Name | Dr Mark D Matthews |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1011 Main St, Cassville, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457348849 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Missouri) | Primary |
| Entity Name | M D M Do Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407808934 PECOS PAC ID: 3173542560 Enrollment ID: O20051115000566 |
News Archive
The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
While there are many benefits of losing weight, weight reduction also might negatively affect bones in the body. During weight loss, bones are being remodeled - breaking down old bone and forming new bone - at an accelerated rate.
In the healthy rat, prolonged exposure to carbon monoxide (CO) under conditions that mimic urban pollution leads to changes to cardiac morphology and function. Compensatory mechanisms develop in these animals to sustain normal cardiac activity, but they become more vulnerable to heart disease.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark D Matthews, DO 101-1 Main St, Cassville, MO 65625-1335 Ph: (417) 846-2277 | Dr Mark D Matthews, DO 1011 Main St, Cassville, MO 65625-1335 Ph: (417) 846-2277 |
News Archive
The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
While there are many benefits of losing weight, weight reduction also might negatively affect bones in the body. During weight loss, bones are being remodeled - breaking down old bone and forming new bone - at an accelerated rate.
In the healthy rat, prolonged exposure to carbon monoxide (CO) under conditions that mimic urban pollution leads to changes to cardiac morphology and function. Compensatory mechanisms develop in these animals to sustain normal cardiac activity, but they become more vulnerable to heart disease.
A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
› Verified 3 days ago
Dr. Jaime Zengotita, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Plz, Cassville, MO 65625 Phone: 417-847-5225 Fax: 417-847-5425 | |
Mr. Timothy Scott Harton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 94 Main St., Cassville, MO 65625 Phone: 417-847-6000 Fax: 870-226-6554 | |
Dr. Connie Lynn Butler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 Main St, Cassville, MO 65625 Phone: 417-847-5225 Fax: 417-847-5425 | |
Dr. Brian E. Basham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4016 Main St, Cassville, MO 65625 Phone: 417-847-0057 Fax: 417-847-0079 | |
Dr. Michael Kent Payne, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Smithson Dr, Suite A, Cassville, MO 65625 Phone: 417-847-3500 Fax: 417-847-3523 | |
Whitney Davis, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 75 Smithson Dr Ste A, Cassville, MO 65625 Phone: 417-847-3500 Fax: 417-847-3523 |